US Department of Energy
Latest From US Department of Energy
A group at the Lawrence Berkeley National Laboratory believes that a synthetic antioxidant previously shown to reduce apoptosis and enhance cell survival in vitro can ameliorate the symptoms of Huntington’s Disease – and beyond its neuroprotective effects, may even have disease modifying properties. They’ve published the first proof of concept in animals, aiming to bring the compound into human studies.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.